Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c

July 26, 2011 4:24 PM EDT Send to a Friend
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Add Your Comment